Gas Plasma Technology Augments Ovalbumin Immunogenicity and OT‐II T Cell Activation Conferring Tumor Protection in Mice

Gas Plasma Technology Augments Ovalbumin Immunogenicity and OT‐II T Cell Activation Conferring Tumor Protection in Mice

Abstract Reactive oxygen species (ROS/RNS) are produced during inflammation and elicit protein modifications, but the immunological consequences are largely unknown. Gas plasma technology capable of generating an unmatched variety of ROS/RNS is deployed to mimic inflammation and study the significan...

Full description

Bibliographic Details
Main Authors: Ramona Clemen, Eric Freund, Daniel Mrochen, Lea Miebach, Anke Schmidt, Bernhard H. Rauch, Jan‐Wilm Lackmann, Ulrike Martens, Kristian Wende, Michael Lalk, Mihaela Delcea, Barbara M. Bröker, Sander Bekeschus
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:Advanced Science
Subjects:
kINPen
ovalbumin
oxPTM
ROS
vaccines
Online Access:https://doi.org/10.1002/advs.202003395

Internet

https://doi.org/10.1002/advs.202003395

Similar Items